Tauroursodeoxycholic Acid For Treatment Of Primary Biliary Cirrhosis. A Dose-response Study

Effect Decrease
Trial Design Non-controlled trial
Trial Length n/a
Number of Subjects 24
Sex n/a
Notes for this study:
500, 1000, and 1500mg of TUDCA were tested over 6 months to see dose-response effects. There was a insignificant dose-response, with 1500mg being the most effective at reducing liver enzyme levels but 500mg being most economical; total cholesterol was reduced with 1000 and 1500mg.

Diarrhea was the only side-effect noted.